Why does circadian timing of administration matter for immune checkpoint inhibitors’ efficacy?
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Why does circadian timing of administration matter for immune checkpoint inhibitors’ efficacy? ; day:4 ; month:6 ; year:2024 ; pages:1-14
British journal of cancer ; (4.6.2024), 1-14
- Urheber
-
Karaboué, Abdoulaye
Innominato, Pasquale F.
Wreglesworth, Nicholas I.
Duchemann, Boris
Adam, René
Lévi, Francis A.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41416-024-02704-9
- URN
-
urn:nbn:de:101:1-2408112116527.323629629125
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:00 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Karaboué, Abdoulaye
- Innominato, Pasquale F.
- Wreglesworth, Nicholas I.
- Duchemann, Boris
- Adam, René
- Lévi, Francis A.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Neoadjuvant Immune Checkpoint Inhibitor Therapy in Melanoma: Efficacy, Safety and Timing
Circadian rhythms and cancer: implications for timing in therapy
Neurosarcoidosis following Immune Checkpoint Inhibition
Immune Checkpoint Inhibitor Rechallenge After Prior Immune Toxicity
Immune checkpoint analysis in lip cancer
Immune checkpoint inhibitor-related acral vasculitis
Immune checkpoint blockade in ovarian cancer
Immune Checkpoint Blockers and Ovarian Cancer
Cancer immunotherapy beyond immune checkpoint inhibitors
Immune checkpoint therapy in liver cancer
Smoldering myocarditis following immune checkpoint blockade
Immune checkpoint analysis in ear cancer
Neoadjuvant Immune Checkpoint Inhibitor Therapy in Melanoma: Efficacy, Safety and Timing
Circadian rhythms and cancer: implications for timing in therapy
Neurosarcoidosis following Immune Checkpoint Inhibition
Immune Checkpoint Inhibitor Rechallenge After Prior Immune Toxicity
Immune checkpoint analysis in lip cancer
Immune checkpoint inhibitor-related acral vasculitis
Immune checkpoint blockade in ovarian cancer
Immune Checkpoint Blockers and Ovarian Cancer
Cancer immunotherapy beyond immune checkpoint inhibitors
Immune checkpoint therapy in liver cancer
Smoldering myocarditis following immune checkpoint blockade
Immune checkpoint analysis in ear cancer
Neoadjuvant Immune Checkpoint Inhibitor Therapy in Melanoma: Efficacy, Safety and Timing
Circadian rhythms and cancer: implications for timing in therapy
Neurosarcoidosis following Immune Checkpoint Inhibition
Immune Checkpoint Inhibitor Rechallenge After Prior Immune Toxicity
Immune checkpoint analysis in lip cancer
Immune checkpoint inhibitor-related acral vasculitis
Immune checkpoint blockade in ovarian cancer
Immune Checkpoint Blockers and Ovarian Cancer
Cancer immunotherapy beyond immune checkpoint inhibitors
Immune checkpoint therapy in liver cancer
Smoldering myocarditis following immune checkpoint blockade